Literature DB >> 474080

Retinoblastoma in Sweden 1958--1971. A clinical and histopathological study.

E Kock, P Naeser.   

Abstract

This study includes all cases of retinoblastoma reported in Sweden between 1958 and 1971. The incidence of the disease was 1 per 18 000 live births. Only in six cases was there a familial history and five of these cases were bilateral. The tumour was bilateral in 37.5% of all cases. All cases with unilateral tumour had been treated with enucleation. In the bilateral cases one eye had also been enucleated and the other eye treated by local irradiation therapy. Tumour invasion into choroid was found in 29% and into the optic nerve on 11% of the cases. The mortality was only 4.5%.

Entities:  

Mesh:

Year:  1979        PMID: 474080     DOI: 10.1111/j.1755-3768.1979.tb01816.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  5 in total

1.  Retinoblastoma presenting with a cheek mass.

Authors:  Ayotunde Ajaiyeoba; Effiong Akang; Bolutife Olusanya
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

2.  Incidence and survival of retinoblastoma in The Netherlands: a register based study 1862-1995.

Authors:  A C Moll; D J Kuik; L M Bouter; W Den Otter; P D Bezemer; J W Koten; S M Imhof; B P Kuyt; K E Tan
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

3.  Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.

Authors:  S E Coupland; N Bechrakis; A Schüler; I Anagnostopoulos; M Hummel; N Bornfeld; H Stein
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

4.  The genetics of retinoblastoma, revisited.

Authors:  A Naumova; C Sapienza
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

5.  Higher vessel densities in retinoblastoma with local invasive growth and metastasis.

Authors:  Jochen Rössler; Torsten Dietrich; Helena Pavlakovic; Lothar Schweigerer; Werner Havers; Andreas Schüler; Norbert Bornfeld; Harald Schilling
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.